Radiotherapy Reshapes the 3D Genome in Medulloblastoma Cells
Dayna ChallisiD, Richard WilsoniD, Sophie M. NavickasiD, Shannon N. Huskins, Iman AzimiiD, Adele F. HollowayiD, Kate H. Brettingham‐MooreiD, Phillippa C. TaberlayiD
Abstract
Radiotherapy is central to medulloblastoma treatment, yet the molecular and three-dimensional (3D) genome responses to irradiation remain poorly understood. Here, we integrated RNA sequencing, proteomics, and Micro-C to characterise the response of ONS-76 medulloblastoma cells to clinically relevant radiation exposures. A single 2 Gy dose induced widespread transcriptional and proteomic changes, including altered cell adhesion, migration, DNA replication, and ribosome biogenesis pathways. Integrated analysis identified LAMB3 and AKR1B10 as candidate mediators of radioresponse that remained elevated following fractionated irradiation. Micro-C profiling following single and repeated 2 Gy exposures revealed radiation-induced 3D genome remodelling. While global genome organisation remained largely stable, irradiation promoted shifts towards active A compartments, new TAD boundary formation, and transient boundary strengthening. Together, these findings provide the first genome-wide characterisation of radiation-induced 3D chromatin reorganisation in a medulloblastoma model and identify molecular and structural features associated with radioresponse.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate target genes to improve treatment outcomes
S. Choudhary, S. C. Burns, … L. O. Penalva·bioRxiv·Dec 5, 2019
- Chronically radiation-exposed survivor glioblastoma cells display poor response to Chk1 inhibition
N. Pinarbasi Degirmenci, I. Sur-Erdem, … T. Bagci-Onder·bioRxiv·Apr 16, 2022
- BCL6 is a context-dependent mediator of the glioblastoma response to irradiation therapy
A. Tribe, L. Peng, … M. J. McConnell·bioRxiv·May 29, 2023
- Concomitant chemotherapy increases radiotherapy-mediated DNA-damage in peripheral blood lymphocytes
Y. Lorat, J. Fleckenstein, … C. Rübe·bioRxiv·Feb 4, 2019
- Single-Cell Multiomic Profiling Uncovers Radiation Dosage-Sensitive, Cluster-Specific Regulatory Dynamics in Glioblastoma
Khoi Huynh, Sara Nalina Barcik Weissman, … Aram Sandaldjian Modrek·bioRxiv·Dec 3, 2025
- XRRA1 acts as a molecular brake on radiation-induced DNA damage signaling and immunogenic cell death in tumor cells.
Tanvi Qamar, Saba Ubaid, … Vivek Kumar Singh·bioRxiv·Apr 24, 2026